Author:
Naumenko Victor,Van Shinia,Dastidar Himika,Kim Dae-Sun,Kim Seok-Joo,Zeng Zhutian,Deniset Justin,Lau Arthur,Zhang Chunfen,Macia Nicolas,Heyne Belinda,Jenne Craig N.,Mahoney Douglas J.
Funder
Canadian Foundation for Innovation
Canadian Cancer Society Research Institute
Canada Research Chairs program
Snyder Institute for Chronic Disease
Alberta Children’s Hospital Foundation
Subject
Pharmacology (medical),Cancer Research,Oncology,Molecular Medicine
Reference56 articles.
1. Viruses for tumor therapy;Bell;Cell Host Microbe,2014
2. Going viral with cancer immunotherapy;Lichty;Nat. Rev. Cancer,2014
3. Oncolytic Virus Approved To Treat Melanoma;Schmidt;J. Natl. Cancer Inst.,2016
4. Inman, S. (2016). Oncolytic poliovirus receives breakthrough designation for glioblastoma. https://www.onclive.com/web-exclusives/oncolytic-poliovirus-receives-breakthrough-designation-for-glioblastoma.
5. Panjwani, L. (2015). FDA grants reolysin orphan drug designation for ovarian cancer. https://www.onclive.com/web-exclusives/fda-grants-reolysin-orphan-drug-designation-for-ovarian-cancer#sthash.SNDHB7Kc.dpuf.
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献